|
USP22 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.10740000006204E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.9604999999554E-06 |
| Normal-vs-Stage2 |
6.206500E-02 |
| Normal-vs-Stage3 |
7.111600E-02 |
| Normal-vs-Stage4 |
1.847790E-01 |
| Stage1-vs-Stage2 |
5.430200E-01 |
| Stage1-vs-Stage3 |
5.766200E-01 |
| Stage1-vs-Stage4 |
1.194320E-02 |
| Stage2-vs-Stage3 |
9.277000E-01 |
| Stage2-vs-Stage4 |
2.535500E-02 |
| Stage3-vs-Stage4 |
5.327600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24100000007144E-07 |
| Normal-vs-AfricanAmerican |
1.155280E-03 |
| Normal-vs-Asian |
6.436400E-01 |
| Caucasian-vs-AfricanAmerican |
2.602200E-01 |
| Caucasian-vs-Asian |
1.330580E-01 |
| AfricanAmerican-vs-Asian |
8.660400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62590999999157E-05 |
| Normal-vs-Female |
2.27680000000063E-05 |
| Male-vs-Female |
1.606390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.935800E-02 |
| Normal-vs-Extreme_Weight |
1.727510E-02 |
| Normal-vs-Obese |
7.85110000000033E-05 |
| Normal-vs-Extreme_Obese |
7.154400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.552600E-01 |
| Normal_Weight-vs-Obese |
1.896210E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.614440E-01 |
| Extreme_Weight-vs-Obese |
1.512420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.444610E-01 |
| Obese-vs-Extreme_Obese |
4.053400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.522200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.94250000213381E-08 |
| Normal-vs-Age(61-80Yrs) |
1.221910E-03 |
| Normal-vs-Age(81-100Yrs) |
7.794400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.984600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.640220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.417600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.374100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.850300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.256800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40610001420072E-09 |
| Normal-VS-Type2 PRCC |
1.870190E-01 |
| Normal-VS-KIRP CIMP |
7.362800E-01 |
| Normal-VS-Unclassified PRCC |
6.810400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.216020E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.047700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.050200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.535600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.316200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.751900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.216200E-01 |
| Normal-vs-N1 |
7.724500E-02 |
| Normal-vs-N2 |
1.321950E-02 |
| N0-vs-N1 |
4.600600E-01 |
| N0-vs-N2 |
1.644390E-01 |
| N1-vs-N2 |
7.821500E-02 |
|
|
